Li, Z., Richards, S., Surks, H. K., Jacobs, A., & Panzara, M. A. (2018). Clinical pharmacology of alemtuzumab, an anti‐CD52 immunomodulator, in multiple sclerosis. Clin Exp Immunol.
シカゴスタイル引用形Li, Z., S. Richards, H. K. Surks, A. Jacobs, , M. A. Panzara. "Clinical Pharmacology of Alemtuzumab, an Anti‐CD52 Immunomodulator, in Multiple Sclerosis." Clin Exp Immunol 2018.
MLA引用形式Li, Z., et al. "Clinical Pharmacology of Alemtuzumab, an Anti‐CD52 Immunomodulator, in Multiple Sclerosis." Clin Exp Immunol 2018.
警告: この引用は必ずしも正確ではありません.